Search Page

1

Cite

Share

Diabetes and oral oncogenesis.

Vairaktaris E, Spyridonidou S, Goutzanis L, Vylliotis A, Lazaris A, Donta I, Perrea D, Yapijakis C, Patsouris E. Vairaktaris E, et al. Among authors: spyridonidou s. Anticancer Res. 2007 Nov-Dec;27(6B):4185-93. Anticancer Res. 2007. PMID: 18225590 Free article. Review.

Cite

Share

2

Cite

Share

The hamster model of sequential oral oncogenesis.

Vairaktaris E, Spyridonidou S, Papakosta V, Vylliotis A, Lazaris A, Perrea D, Yapijakis C, Patsouris E. Vairaktaris E, et al. Among authors: spyridonidou s. Oral Oncol. 2008 Apr;44(4):315-24. doi: 10.1016/j.oraloncology.2007.08.015. Epub 2007 Dec 3. Oral Oncol. 2008. PMID: 18061531 Review.

Cite

Share

3

Cite

Share

Diabetes does not influence oral oncogenesis through fibroblast growth factor receptors.

Vairaktaris E, Goutzanis L, Nkenke E, Spyridonidou S, Vassiliou S, Derka S, Vylliotis A, Yapijakis C, Lazaris A, Strantzias P, Kalimeras E, Patsouris E. Vairaktaris E, et al. Among authors: spyridonidou s. In Vivo. 2007 Jul-Aug;21(4):623-8. In Vivo. 2007. PMID: 17708356 Free article.

Cite

Share

4

Cite

Share

Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with decreased risk for basal cell carcinoma.

Yapijakis C, Koronellos N, Spyridonidou S, Vylliotis A, Avgoustidis D, Goutas N, Vlachodimitropoulos D, Vairaktaris E. Yapijakis C, et al. Among authors: spyridonidou s. Arch Dermatol Res. 2013 May;305(4):333-9. doi: 10.1007/s00403-012-1312-7. Epub 2013 Jan 9. Arch Dermatol Res. 2013. PMID: 23299466

Cite

Share

5

Cite

Share

A common 9 bp deletion in the ataxia-telangiectasia-mutated gene is not associated with oral cancer.

Spyridonidou S, Yapijakis C, Nkenke E, Toyoshima T, Vylliotis A, Serefoglou Z, Neukam FW, Patsouris E, Vairaktaris E. Spyridonidou S, et al. Anticancer Res. 2009 Aug;29(8):3191-3. Anticancer Res. 2009. PMID: 19661334 Free article.

Cite

Share

6

Cite

Share

Diabetes alters expression of p53 and c-myc in different stages of oral oncogenesis.

Vairaktaris E, Kalokerinos G, Goutzanis L, Spyridonidou S, Vassiliou S, Derka S, Nkenke E, Yapijakis C, Vylliotis A, Lazaris A, Patsouris E. Vairaktaris E, et al. Among authors: spyridonidou s. Anticancer Res. 2007 May-Jun;27(3B):1465-73. Anticancer Res. 2007. PMID: 17595763 Free article.

Cite

Share

7

Cite

Share

Loss of tumour suppressor p16 expression in initial stages of oral oncogenesis.

Vairaktaris E, Yapijakis C, Psyrri A, Spyridonidou S, Yannopoulos A, Lazaris A, Vassiliou S, Ferekidis E, Vylliotis A, Nkenke E, Patsouris E. Vairaktaris E, et al. Among authors: spyridonidou s. Anticancer Res. 2007 Mar-Apr;27(2):979-84. Anticancer Res. 2007. PMID: 17465230 Free article.

Cite

Share

8

Cite

Share

Cell proliferation and apoptosis culminate in early stages of oral oncogenesis.

Derka S, Vairaktaris E, Papakosta V, Vassiliou S, Acil Y, Vylliotis A, Spyridonidou S, Lazaris AC, Mourouzis C, Kokkori A, Moulavasili P, Perrea D, Donta I, Yapijakis C, Patsouris E. Derka S, et al. Among authors: spyridonidou s. Oral Oncol. 2006 May;42(5):540-50. doi: 10.1016/j.oraloncology.2005.10.008. Epub 2006 Feb 7. Oral Oncol. 2006. PMID: 16464633

Cite

Share

9

Cite

Share

Expression of cell cycle regulator p16 is not affected by diabetes during oral oncogenesis.

Vairaktaris E, Goutzanis L, Nkenke E, Spyridonidou S, Vassiliou S, Derka S, Vylliotis A, Yapijakis C, Lazaris A, Patsouris E. Vairaktaris E, et al. Among authors: spyridonidou s. In Vivo. 2007 Sep-Oct;21(5):745-50. In Vivo. 2007. PMID: 18019407 Free article.

Cite

Share

10

Cite

Share

FGFR-2 and -3 play an important role in initial stages of oral oncogenesis.

Vairaktaris E, Ragos V, Yapijakis C, Derka S, Vassiliou S, Nkenke E, Yannopoulos A, Spyridonidou S, Vylliotis A, Papakosta V, Loukeri S, Lazaris A, Tesseromatis C, Tsigris C, Patsouris E. Vairaktaris E, et al. Among authors: spyridonidou s. Anticancer Res. 2006 Nov-Dec;26(6B):4217-21. Anticancer Res. 2006. PMID: 17201136 Free article.

Cite

Share